Cargando…
The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors
Background: Recent expiry of patents for tumor necrosis factor (TNF)-α inhibitors has led to the employment of biosimilars in clinical practice. The aim of the study was to identify any change in the control of ocular inflammatory manifestations among patients with non-infectious uveitis switching f...
Autores principales: | Fabiani, Claudia, Vitale, Antonio, Emmi, Giacomo, Sgheri, Arianna, Lopalco, Giuseppe, Sota, Jurgen, Guerriero, Silvana, Iannone, Florenzo, Frediani, Bruno, Vannozzi, Lorenzo, Bianco, Maria Teresa, Giovannini, Valtere, Tosi, Gian Marco, Cantarini, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913067/ https://www.ncbi.nlm.nih.gov/pubmed/31920658 http://dx.doi.org/10.3389/fphar.2019.01468 |
Ejemplares similares
-
Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021) -
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience
por: Sota, Jurgen, et al.
Publicado: (2020) -
New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy
por: Fabiani, Claudia, et al.
Publicado: (2020) -
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study
por: Bitossi, Alice, et al.
Publicado: (2019) -
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis
por: Gentileschi, Stefano, et al.
Publicado: (2020)